Litcius/Paper detail

Sotorasib for previously treated colorectal cancers with KRASG12C mutation (CodeBreaK100): a prespecified analysis of a single-arm, phase 2 trial

Marwan G Fakih, Scott Kopetz, Yasutoshi Kuboki, Tae Won Kim, Pamela N Munster, John C Krauss, Gerald S Falchook, Sae-Won Han, Volker Heinemann, Kei Muro, John H Strickler, David S Hong, Crystal S Denlinger, Gustavo Girotto, Myung-Ah Lee, Haby Henary, Qui Tran, Joseph K Park, Gataree Ngarmchamnanrith, Hans Prenen, Timothy J Price

2021The Lancet Oncology288 citationsDOI

Topics & Concepts

MedicineInternal medicineOncologyMutationColorectal cancerClinical trialCancerPhases of clinical researchCancer researchPhase (matter)ChemotherapyMutation testingColorectal Cancer Treatments and StudiesPARP inhibition in cancer therapyColorectal Cancer Surgical Treatments